NIKKEI 225
38,162.30 -111.75 (-0.29%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
79.19 +0.19 (+0.24%) GOLD FUTURES
2,333.60 +22.60 (+0.98%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
46,117.20 -1,783.90 (-3.72%)
Amicus Therapeutics, Inc. (FOLD)
After hours:
| Previous close | 9.99 |
| Open | 10.09 |
| Bid | 10.40 x 900 |
| Ask | 10.43 x 700 |
| Day's range | 9.98 - 10.60 |
| 52-week range | 9.70 - 14.57 |
| Volume | |
| Avg. volume | 3,031,424 |
| Market cap | 3.089B |
| Beta (5Y monthly) | 0.76 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024
PRINCETON, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, May 9, 2024, at 8:30 a.m. ET to discuss financial results for the first quarter ended March 31, 2024. Participants and investors interested in accessing the call by phone will need to register using the online registration form. After registering, all phone participants will receive a dial-in number along with a pers
- GlobeNewswire
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report
PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, today issued its fourth annual Environmental, Social, and Governance (ESG) report. This year’s report highlights the strength of the Company’s corporate responsibility structure including increased efforts towards transparency in our environmental reporting, our deep commitment to ensu
- GlobeNewswire
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024
PRINCETON, N.J., March 01, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in March. Cowen 44th Annual Health Care Conference in Boston, MA, on Monday, March 4, 2024, at 11:10 a.m. E.T.Leerink Partners 2024 Global Biopharma Conference in Miami, FL on Monday, March 11, 2024, at 3:20 p.m. E.T. A live audio webcast of each presentation can also be accessed via the investors s
